These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9152390)

  • 1. Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability.
    Thomas SA; Abbruscato TJ; Hau VS; Gillespie TJ; Zsigo J; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 May; 281(2):817-25. PubMed ID: 9152390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
    J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helix-inducing alpha-aminoisobutyric acid in opioid mimetic deltorphin C analogues.
    Bryant SD; Guerrini R; Salvadori S; Bianchi C; Tomatis R; Attila M; Lazarus LH
    J Med Chem; 1997 Aug; 40(16):2579-87. PubMed ID: 9258365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of combined chemical modifications to enhance the blood-brain barrier permeability and pharmacological activity of endomorphin-1.
    Liu HM; Liu XF; Yao JL; Wang CL; Yu Y; Wang R
    J Pharmacol Exp Ther; 2006 Oct; 319(1):308-16. PubMed ID: 16803861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [D-Ala2]-Deltorphin I peptoid and retropeptoid analogues: synthesis, biological activity and conformational investigations.
    Biondi L; Giannini E; Filira F; Gobbo M; Negri L; Rocchi R
    J Pept Sci; 2004 Sep; 10(9):578-87. PubMed ID: 15473265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.
    Greene DL; Hau VS; Abbruscato TJ; Bartosz H; Misicka A; Lipkowski AW; Hom S; Gillespie TJ; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1366-75. PubMed ID: 8667199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception.
    Sánchez-Blázquez P; Garzón J
    J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ; Qian X; Hruby VJ; Porreca F
    J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.
    Gao B; Hagenbuch B; Kullak-Ublick GA; Benke D; Aguzzi A; Meier PJ
    J Pharmacol Exp Ther; 2000 Jul; 294(1):73-9. PubMed ID: 10871297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells.
    Stefano GB; Melchiorri P; Negri L; Hughes TK; Scharrer B
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9316-20. PubMed ID: 1329092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors.
    Lazarus LH; Salvadori S; Balboni G; Tomatis R; Wilson WE
    J Med Chem; 1992 Apr; 35(7):1222-7. PubMed ID: 1313878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
    Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
    J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of antiserum to [D-Ala2]deltorphin I and its immunohistochemical application to the mouse brain.
    Abe H; Tooyama I; Renda T; Ersparmer V; Kimura H
    Neuroreport; 1992 Aug; 3(8):669-72. PubMed ID: 1520852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved blood-brain barrier penetration and enhanced analgesia of an opioid peptide by glycosylation.
    Egleton RD; Mitchell SA; Huber JD; Palian MM; Polt R; Davis TP
    J Pharmacol Exp Ther; 2001 Dec; 299(3):967-72. PubMed ID: 11714884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the synthesis and structure-activity relation of deltorphin I analogues].
    Hu XY; Wang R; Jia Q; Wang Q
    Yao Xue Xue Bao; 1995; 30(9):679-84. PubMed ID: 8701744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration.
    Negri L; Lattanzi R; Tabacco F; Scolaro B; Rocchi R
    Br J Pharmacol; 1998 Aug; 124(7):1516-22. PubMed ID: 9723966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of dynorphin a analogues modified in the address sequence.
    Schlechtingen G; DeHaven RN; Daubert JD; Cassel JA; Chung NN; Schiller PW; Taulane JP; Goodman M
    J Med Chem; 2003 May; 46(11):2104-9. PubMed ID: 12747782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide.
    Koda Y; Shiotani K; Toth I; Tsuda Y; Okada Y; Blanchfield JT
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2043-6. PubMed ID: 17300932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K; Varga EV; Alfaro-Lopez J; Tang X; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of an in vitro blood-brain barrier model using several [Met5]enkephalin opioid analogs.
    Weber SJ; Abbruscato TJ; Brownson EA; Lipkowski AW; Polt R; Misicka A; Haaseth RC; Bartosz H; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1649-55. PubMed ID: 8371162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.